Screening for retinopathy of prematurity in South Africa: are those developing severe ROP screened on time? Data from a prospective register

Background/Aims To determine whether retinopathy of prematurity (ROP) screening is initiated on time according to current South African (SA) guidelines, that is, before the onset of stage 3 and type 1 ROP.Methods A prospective study of preterm infants screened at five neonatal units between 1 May 20...

Full description

Saved in:
Bibliographic Details
Main Authors: Esme Jordaan, Rudzani Muloiwa, Adrie Bekker, Gerd Holmström, Clare Gilbert, Michael Harrison, Nicola Freeman, Lloyd Tooke, Phumza Nongena, Natasha Rhoda, Tshilidzi van der Lecq, Teboho Seobi, Linda Visser, Shakti Pillay, Nicole Meiring, Jaco Murray, Adriaan Daniels, Helga Abrahamse-Pillay, Gugulabatembunamahlubi Kali, Miemie Du Preez, Alexander Geragotellis, Neeran Reddy
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:BMJ Open Ophthalmology
Online Access:https://bmjophth.bmj.com/content/10/1/e002239.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849718036468072448
author Esme Jordaan
Rudzani Muloiwa
Adrie Bekker
Gerd Holmström
Clare Gilbert
Michael Harrison
Nicola Freeman
Lloyd Tooke
Phumza Nongena
Natasha Rhoda
Tshilidzi van der Lecq
Teboho Seobi
Linda Visser
Tshilidzi van der Lecq
Shakti Pillay
Nicole Meiring
Jaco Murray
Adriaan Daniels
Helga Abrahamse-Pillay
Gugulabatembunamahlubi Kali
Miemie Du Preez
Alexander Geragotellis
Neeran Reddy
author_facet Esme Jordaan
Rudzani Muloiwa
Adrie Bekker
Gerd Holmström
Clare Gilbert
Michael Harrison
Nicola Freeman
Lloyd Tooke
Phumza Nongena
Natasha Rhoda
Tshilidzi van der Lecq
Teboho Seobi
Linda Visser
Tshilidzi van der Lecq
Shakti Pillay
Nicole Meiring
Jaco Murray
Adriaan Daniels
Helga Abrahamse-Pillay
Gugulabatembunamahlubi Kali
Miemie Du Preez
Alexander Geragotellis
Neeran Reddy
collection DOAJ
description Background/Aims To determine whether retinopathy of prematurity (ROP) screening is initiated on time according to current South African (SA) guidelines, that is, before the onset of stage 3 and type 1 ROP.Methods A prospective study of preterm infants screened at five neonatal units between 1 May 2022 and 31 January 2023 in Cape Town, SA. Data on all infants screened with a birth weight <1250 g or gestational age (GA) <32 weeks were extracted from the ROP South African (ROPSA) register, including postnatal age (PNA) and postmenstrual age (PMA) at first screening.Results A total of 696 infants were included, 58.9% (n=410) of whom had an early ultrasound (EUS) for GA estimation. Overall, 220 (31.6%) infants developed ROP, 20 (2.9%) had stage 3 or type 1 and 7 (1.0%) required treatment. Screening was initiated on time according to SA criteria in 549 (78.9%) infants, none of whom had stage 3 or type 1 ROP at first screening. Stage 3 and type 1 ROP were first detected at PNA and PMA of 6.3 and 33.1 and 8.9 and 35.9 weeks, respectively. Most infants (319, 45.8%) were screened according to PNA only, and 78.9% of the 185 infants screened only once did not attend subsequent examinations.Conclusion Screening started on time in most infants and prior to the development of severe ROP. Due to the limited availability of EUS in our region and to promote complete screening, we recommend that screening be initiated using PNA alone at 4–6 weeks or prior to discharge, whichever is earliest. The low proportion of infants with stage 3 and type 1 ROP is a limitation in our study. Therefore, recommendations may not be generalisable to South African regions where neonatal care results in a higher proportion of infants developing type 1 ROP.
format Article
id doaj-art-de3e3a000f704285affca31166fcc1aa
institution DOAJ
issn 2397-3269
language English
publishDate 2025-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Ophthalmology
spelling doaj-art-de3e3a000f704285affca31166fcc1aa2025-08-20T03:12:30ZengBMJ Publishing GroupBMJ Open Ophthalmology2397-32692025-07-0110110.1136/bmjophth-2025-002239Screening for retinopathy of prematurity in South Africa: are those developing severe ROP screened on time? Data from a prospective register Esme Jordaan0Rudzani Muloiwa1Adrie BekkerGerd Holmström2Clare Gilbert3Michael HarrisonNicola Freeman4Lloyd Tooke5Phumza NongenaNatasha Rhoda6Tshilidzi van der Lecq7Teboho SeobiLinda VisserTshilidzi van der LecqShakti PillayNicole MeiringJaco MurrayAdriaan DanielsHelga Abrahamse-PillayGugulabatembunamahlubi KaliMiemie Du PreezAlexander GeragotellisNeeran ReddyBiostatistics Research Unit, South African Medical Research Council, Cape Town, South AfricaDepartment of Paediatrics & Child Health, University of Cape Town, Cape Town, South AfricaDepartment of Surgical Sciences, Ophthalmology, Uppsala University, Uppsala, SwedenClinical Research, London School of Hygiene and Tropical Medicine, London, UKDepartment of Surgery, Division of Ophthalmology, University of Cape Town, Cape Town, South AfricaDepartment of Paediatrics & Child Health, University of Cape Town, Cape Town, South AfricaDepartment of Paediatrics & Child Health, University of Cape Town, Cape Town, South AfricaDepartment of Surgery, Division of Ophthalmology, University of Cape Town, Cape Town, South AfricaBackground/Aims To determine whether retinopathy of prematurity (ROP) screening is initiated on time according to current South African (SA) guidelines, that is, before the onset of stage 3 and type 1 ROP.Methods A prospective study of preterm infants screened at five neonatal units between 1 May 2022 and 31 January 2023 in Cape Town, SA. Data on all infants screened with a birth weight <1250 g or gestational age (GA) <32 weeks were extracted from the ROP South African (ROPSA) register, including postnatal age (PNA) and postmenstrual age (PMA) at first screening.Results A total of 696 infants were included, 58.9% (n=410) of whom had an early ultrasound (EUS) for GA estimation. Overall, 220 (31.6%) infants developed ROP, 20 (2.9%) had stage 3 or type 1 and 7 (1.0%) required treatment. Screening was initiated on time according to SA criteria in 549 (78.9%) infants, none of whom had stage 3 or type 1 ROP at first screening. Stage 3 and type 1 ROP were first detected at PNA and PMA of 6.3 and 33.1 and 8.9 and 35.9 weeks, respectively. Most infants (319, 45.8%) were screened according to PNA only, and 78.9% of the 185 infants screened only once did not attend subsequent examinations.Conclusion Screening started on time in most infants and prior to the development of severe ROP. Due to the limited availability of EUS in our region and to promote complete screening, we recommend that screening be initiated using PNA alone at 4–6 weeks or prior to discharge, whichever is earliest. The low proportion of infants with stage 3 and type 1 ROP is a limitation in our study. Therefore, recommendations may not be generalisable to South African regions where neonatal care results in a higher proportion of infants developing type 1 ROP.https://bmjophth.bmj.com/content/10/1/e002239.full
spellingShingle Esme Jordaan
Rudzani Muloiwa
Adrie Bekker
Gerd Holmström
Clare Gilbert
Michael Harrison
Nicola Freeman
Lloyd Tooke
Phumza Nongena
Natasha Rhoda
Tshilidzi van der Lecq
Teboho Seobi
Linda Visser
Tshilidzi van der Lecq
Shakti Pillay
Nicole Meiring
Jaco Murray
Adriaan Daniels
Helga Abrahamse-Pillay
Gugulabatembunamahlubi Kali
Miemie Du Preez
Alexander Geragotellis
Neeran Reddy
Screening for retinopathy of prematurity in South Africa: are those developing severe ROP screened on time? Data from a prospective register
BMJ Open Ophthalmology
title Screening for retinopathy of prematurity in South Africa: are those developing severe ROP screened on time? Data from a prospective register
title_full Screening for retinopathy of prematurity in South Africa: are those developing severe ROP screened on time? Data from a prospective register
title_fullStr Screening for retinopathy of prematurity in South Africa: are those developing severe ROP screened on time? Data from a prospective register
title_full_unstemmed Screening for retinopathy of prematurity in South Africa: are those developing severe ROP screened on time? Data from a prospective register
title_short Screening for retinopathy of prematurity in South Africa: are those developing severe ROP screened on time? Data from a prospective register
title_sort screening for retinopathy of prematurity in south africa are those developing severe rop screened on time data from a prospective register
url https://bmjophth.bmj.com/content/10/1/e002239.full
work_keys_str_mv AT screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT esmejordaan screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT rudzanimuloiwa screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT adriebekker screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT gerdholmstrom screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT claregilbert screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT michaelharrison screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT nicolafreeman screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT lloydtooke screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT phumzanongena screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT natasharhoda screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT tshilidzivanderlecq screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT tebohoseobi screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT lindavisser screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT tshilidzivanderlecq screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT shaktipillay screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT nicolemeiring screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT jacomurray screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT adriaandaniels screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT helgaabrahamsepillay screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT gugulabatembunamahlubikali screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT miemiedupreez screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT alexandergeragotellis screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister
AT neeranreddy screeningforretinopathyofprematurityinsouthafricaarethosedevelopingsevereropscreenedontimedatafromaprospectiveregister